Donald Bruce Burlington

Donald Bruce Burlington currently works at International Partnership for Microbicides, as Non-Executive Director.
Dr. Burlington also formerly worked at AstraZeneca PLC, as Independent Non-Executive Director from 2010 to 2017, Cangene Corp., as Independent Director from 2012 to 2013, US Food & Drug Administration, as Director, Center for Drug Evaluation & Research, as Deputy Director-Medical Affairs in 1993, Center for Devices & Radiological Health, as Director in 1999, Center for Biologics Evaluation & Research, as Director-Biological Investigational New Drugs in 1989, Biosurface Engineering Technologies, Inc., as Regulatory Affairs Officer from 2014 to 2015, Wyeth Pharmaceuticals LLC, as Executive VP-Business Practices & Compliance in 2007, and Pharmaceutical Research & Manufacturers of America, as Principal.
Dr. Burlington received his doctorate degree in 1976 from Louisiana State University.